Invest in the best stock opportunities right now and every-time.
Start Systematic Stock Investing ...in less than a minute.
Jubilant Ingrevia is currently trading at Rs. 456.60, up by 4.90 points or 1.08% from its previous closing of Rs. 451.70 on the BSE.
The scrip opened at Rs. 454.25 and has touched a high and low of Rs. 466.15 and Rs. 454.25 respectively. So far 2422 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 524.50 on 07-Sep-2023 and a 52 week low of Rs. 357.00 on 31-Mar-2023.
Last one week high and low of the scrip stood at Rs. 466.15 and Rs. 440.50 respectively. The current market cap of the company is Rs. 7194.73 crore.
The promoters holding in the company stood at 51.47%, while Institutions and Non-Institutions held 17.53% and 30.99% respectively.
Jubilant Ingrevia has commissioned a new facility at its manufacturing site for Diketene derivatives at Gajraula, Uttar Pradesh. As a global, integrated life science products and innovative solutions provider, the company presently has over 134 products & innovative solutions commercialised. With over four decades of experience, it has developed proficiency across around 35 key chemistry and technology platforms across its businesses: Specialty, Nutrition and Chemical Intermediates.
The newly commissioned facility adds additional capacity of 2,000 TPA to produce high-value esters. This strengthening of the Diketene and derivatives platform marks a natural evolution of strategy in the Specialty Chemicals segment. This business is pivoting towards accelerated growth and higher margins with the introduction of several downstream derivatives.
In line with its long-term strategic objectives, Jubilant Ingrevia remains committed to commissioning of future phases of Diketene derivatives. In addition to existing clients the expanded range of diketene derivatives will be aimed at a new category of customers in key international markets, including the U.S and E.U regions.
Jubilant Ingrevia, a global integrated Life Science products and Innovative Solutions provider serving, Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers.
| Company Name | CMP |
|---|---|
| Tata Chemicals | 1064.50 |
| SRF | 2286.00 |
| Pidilite Inds. | 2983.65 |
| Aarti Inds | 653.05 |
| Gujarat Fluorochemic | 3258.70 |
| View more.. | |
MoneyWorks4Me rating and ranking of funds for SIP is available to subscribers only. Moneyworks4Me is not a rating and ranking agency, however it is required that users have a way of selecting funds and building a Portfolio. The method used by it are described below to enable users to understand the logic behind the rating and ranking Subscriber will find more details on this in the various content made available from time to time. In case you need more please write to besafe@moneyworks4Me.com
MoneyWorks4Me rates and ranks mutual funds based on the following data-driven system:
Funds ranking in screeners: Performance Consistency and Quality are two parameters used for ranking funds for SIP. The ranking as follows GG, GO, GR, OG, OO, OR, RG, RO and RR.
With the same color-coded funds, the one with the higher Average 3-year rolling returns (over 5 to 10 years), the number that appears in the Performance tag, ranks higher.
Here is the summary:
The third tag Upside Potential is not relevant for SIP. It is relevant for lumpsum investments in Mutual Funds.
Buy quality Stocks when they are available at reasonable prices and supported by an upward price trend and Sell when they are Overvalued using the Decizen Rating System. Covers 3500+ stocks
Download APP
